- Home
- MIRM vs DBX Comparison
MIRM vs DBX Comparison
Compare MIRM & DBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRM | DBX |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.9B |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MIRM | DBX |
|---|---|---|
| Price | $93.42 | $36.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 8 |
| Target Price | ★ $119.85 | $28.14 |
| AVG Volume (30 Days) | 456.7K | ★ 3.4M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | 32.86 |
| EPS | N/A | ★ 0.91 |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | $0.20 |
| Revenue Next Year | $22.04 | N/A |
| P/E Ratio | ★ N/A | $41.33 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $63.23 | $21.70 |
| 52 Week High | $130.00 | $38.17 |
Technical Indicators
Market Signals| Indicator | MIRM | DBX |
|---|---|---|
| Relative Strength Index (RSI) | 38.75 | 59.86 |
| Support Level | $88.08 | $33.25 |
| Resistance Level | $98.03 | N/A |
| Average True Range (ATR) | 3.82 | 1.07 |
| MACD | -0.03 | 0.12 |
| Stochastic Oscillator | 1.32 | 70.37 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About DBX Dropbox Inc.
Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.